Comparison of two topical piroxicam and EMLA cream on fistula cannulation pain in hemodialysis patient

orestan University of Medical Sciences, Research0 个研究点目标入组 75 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•1. The patient is willing to cooperate and participate in the research.
•2. The patient has given informed consent to participate in research.
•3. Age is between 18-80 years old.
•4. Starting hemodialysis at lease 3 months before.
•5. Patients don’t have verbal disability, mental and vision problems.
•6. Patients don’t have prior history of mental illness or psychiatric hospitalization.
•7. The patient is not addict.
•8. The patient has no pain medication dependency.
•9. The patient has no pain before cannulation.
•10. The patient has not used sedative drugs in the last 24 hours of cannulation .
•11. The fistula skin is not injured.
•12. Patients don’t have history of G6PD, congenital or idiopathic Methemoglobinemia, liver disease, asthma, skin allergies, dermatitis, rash, thrombophlebitis, gastrointestinal bleeding.
•13. Patients don’t have sensitivity to local anesthetic drugs, nonsteroidal anti-inflammatory drugs and other medicines.
•14. Patients not be treated with sulfonamide drugs, nitrates and phenobarbital.
•Exclusion criteria:
•1. Patient does not wish to continue research.
•2. The patient is referred to another center.
•3. If unsuccessful on the first attempt and repeated cannulation needle into the skin.

发起方

orestan University of Medical Sciences, Research